IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
1.970
-0.080 (-3.90%)
At close: Sep 5, 2025, 4:00 PM
1.870
-0.100 (-5.08%)
After-hours: Sep 5, 2025, 5:57 PM EDT
IM Cannabis Revenue
IM Cannabis had revenue of 12.70M CAD in the quarter ending June 30, 2025, a decrease of -13.93%. This brings the company's revenue in the last twelve months to 52.41M, up 5.08% year-over-year. In the year 2024, IM Cannabis had annual revenue of 54.03M with 10.71% growth.
Revenue (ttm)
52.41M CAD
Revenue Growth
+5.08%
P/S Ratio
0.14
Revenue / Employee
551,726 CAD
Employees
95
Market Cap
12.01M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 54.03M | 5.23M | 10.71% |
Dec 31, 2023 | 48.80M | -5.53M | -10.18% |
Dec 31, 2022 | 54.34M | 20.28M | 59.56% |
Dec 31, 2021 | 34.05M | 18.16M | 114.30% |
Dec 31, 2020 | 15.89M | 6.82M | 75.12% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
IMCC News
- 12 hours ago - IM Cannabis Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement - PRNewsWire
- 23 days ago - IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing - PRNewsWire
- 24 days ago - IM Cannabis Reports Second Quarter 2025 Financial Results - PRNewsWire
- 4 weeks ago - IM Cannabis to Report Second Quarter 2025 Financial Results on Tuesday, August 12th at 9:00am ET - PRNewsWire
- 5 weeks ago - IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million - PRNewsWire
- 2 months ago - IM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3 - PRNewsWire
- 2 months ago - IM Cannabis Announces the Signing of a Loan Agreement and Appointment of Oz Adler to Board of Directors - PRNewsWire
- 2 months ago - IM Cannabis Provides Corporate Updates - PRNewsWire